Microglial activation by serum factors

血清因子激活小胶质细胞

基本信息

  • 批准号:
    6906457
  • 负责人:
  • 金额:
    $ 32.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Microglial cells are the resident immune cells of the central nervous system (CNS). They have been implicated in many acute and chronic neurological diseases, including trauma, stroke and multiple sclerosis. Upon CNS injury microglial cells are rapidly activated. Through the release of bioactive substances such as cytokines activated microglial cells can exert powerful toxic as well as protective effects on neurons. Until recently, research has mainly focused on microglial activation by cytokines. These potent peptides elicit a broad range of responses, including proliferation, motility and cytokine release itself. Nevertheless, before cytokines can activate microglia, they need to be induced, synthesized and released from neighboring cells. The reported rapid activation of microglia after CNS injury, leads to the question: Are there other, factors acting as microglial activators? One group of candidates is serum factors (SFs). SFs leak into the CNS parenchyma during insults associated with impairment of the blood-brain-barrier, such as trauma, stroke, and multiple sclerosis. Serum factors therefore could serve as immediate signals of injury and activate microglial cells without the need of intermediary, cytokine- producing "relay" cells. We hypothesize that serum factors (SF) represent a "short-cut" to microglial activation. Based on recently published reports and our preliminary findings, we propose to examine the effects of the serum factors thrombin, lysophosphatidic acid and sphingosine-1 -phospate on microglial Activation. Using molecular, immunological and imaging techniques the following issues will be addressed: 1. Determine the cellular consequences of microglial activation by SFs in vitro. 2. Determine the signal transduction mechanisms involved in SF-mediated microglial activation in vitro. 3. Determine the cellular consequences of microglial activation by SFs in a retina explant culture model in situ. In many pathological events SFs act immediately on microglial cells, long before first-phase cytokines could influence microglial behavior. Each of the receptors or signal transduction mechanisms identified may constitute a new target for therapeutic intervention in CNS injuries, which are accompanied by the break down of the blood-brain-barrier, such as trauma, multiple sclerosis or stroke.
描述(由申请人提供):小胶质细胞是中枢神经系统(CNS)的常驻免疫细胞。它们与许多急性和慢性神经系统疾病有关,包括创伤、中风和多发性硬化症。中枢神经系统损伤后,小胶质细胞迅速被激活。通过释放细胞因子等生物活性物质,激活小胶质细胞对神经元具有强大的毒性和保护作用。直到最近,研究主要集中在细胞因子对小胶质细胞的激活。这些有效的多肽引起广泛的反应,包括增殖、运动和细胞因子释放本身。然而,在细胞因子激活小胶质细胞之前,它们需要被诱导、合成并从邻近细胞中释放出来。据报道,中枢神经系统损伤后小胶质细胞的快速激活引发了一个问题:是否有其他因素作为小胶质细胞激活剂?一组候选因子是血清因子(SFs)。在与血脑屏障损伤相关的损伤(如创伤、中风和多发性硬化症)中,SFs会渗漏到中枢神经系统实质。因此,血清因子可以作为损伤的直接信号,激活小胶质细胞,而不需要中间的细胞因子产生“中继”细胞。我们假设血清因子(SF)代表了小胶质细胞激活的“捷径”。根据最近发表的报告和我们的初步研究结果,我们建议研究凝血酶、溶血磷脂酸和鞘氨醇-1 -磷酸对小胶质细胞激活的影响。使用分子、免疫学和成像技术将解决以下问题:确定体外sf激活小胶质细胞的细胞后果。2. 确定sf介导的小胶质细胞体外激活的信号转导机制。3. 在视网膜外植体原位培养模型中确定SFs激活小胶质细胞的细胞后果。在许多病理事件中,早在第一阶段细胞因子影响小胶质细胞行为之前,SFs就立即作用于小胶质细胞。所发现的每一种受体或信号转导机制都可能构成对伴有血脑屏障破坏的中枢神经系统损伤(如创伤、多发性硬化症或中风)进行治疗干预的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS MOELLER其他文献

THOMAS MOELLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS MOELLER', 18)}}的其他基金

Generation and initial charcterization of a mouse with floxed miR-155 for conditi
具有 floxed miR-155 条件的小鼠的生成和初步表征
  • 批准号:
    7990884
  • 财政年份:
    2010
  • 资助金额:
    $ 32.4万
  • 项目类别:
The role of miRNA in microglia activation
miRNA 在小胶质细胞激活中的作用
  • 批准号:
    7511553
  • 财政年份:
    2008
  • 资助金额:
    $ 32.4万
  • 项目类别:
Microglial activation by serum factors
血清因子激活小胶质细胞
  • 批准号:
    7340328
  • 财政年份:
    2002
  • 资助金额:
    $ 32.4万
  • 项目类别:
Microglial activation by serum factors
血清因子激活小胶质细胞
  • 批准号:
    6637739
  • 财政年份:
    2002
  • 资助金额:
    $ 32.4万
  • 项目类别:
Microglial activation by serum factors
血清因子激活小胶质细胞
  • 批准号:
    6741949
  • 财政年份:
    2002
  • 资助金额:
    $ 32.4万
  • 项目类别:
Microglial activation by serum factors
血清因子激活小胶质细胞
  • 批准号:
    6531373
  • 财政年份:
    2002
  • 资助金额:
    $ 32.4万
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    $ 32.4万
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    $ 32.4万
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    $ 32.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了